Ladki Bahin Yojana:  Transfer of  ₹1,500 resumes for eligible women in Maharashtra | Mint

Ladki Bahin Yojana: Transfer of ₹1,500 resumes for eligible women in Maharashtra | Mint

Source: Live Mint The monthly instalments disbursements under the Ladki Bahin scheme in Maharashtra resumed on Tuesday after an interruption due to the model code of conduct. The instalments for the beneficiaries will be disbursed in phases, PTI reported, citing the Women and Child Development Minister Aditi Tatkare. The model code of conduct was enforced…

Read More
This solid aluminum keyboard costs as much as a MacBook Pro

This solid aluminum keyboard costs as much as a MacBook Pro

Source: The Verge If statement keyboards are your thing and you have some serious cash to burn, you should check out this brutalist flagship offering from Serene Industries. The Icebreaker is a wedge-shaped mechanical keyboard constructed from a single block of CNC-machined aluminum, featuring hot-swappable aluminum keycaps with configurable RGB backlighting. Preorders are available now,…

Read More
The Sell-Off Doesn’t Deter Institutional Crypto Investors

The Sell-Off Doesn’t Deter Institutional Crypto Investors

Source: Bitcoinist The small fish may be reacting to market-wide selling pressure, but institutional crypto investors have adopted a different stance, pouring hundreds of millions into digital asset investment vehicles last week.  According to a CoinShares report, digital asset investment products saw inflows totaling $308M, masking December 19’s $576M outflows (the single largest day). Total…

Read More
Biocon stock settles 5% higher after US drug regulator clears Bengaluru API facility unit, stock up 35% YTD | Stock Market News

Biocon stock settles 5% higher after US drug regulator clears Bengaluru API facility unit, stock up 35% YTD | Stock Market News

Source: Live Mint Biocon stock price: Shares of Biocon extended gains to settle five per cent higher on Tuesday, December 24 after the United States Food and Drug Administration (USFDA) issued an Establishment Inspection Report (EIR) with a Voluntary Action Status (VAI) for its Active Pharmaceutical Ingredients (API) facility in Bengaluru. Read Full Article

Read More